USPTO serial 99932817
FRONTIERS
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- WRIGHT, MARCO JABBAR
- Law office
- TMO LAW OFFICE 120
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with FRONTIERS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William R. Samuels
201 California street, Suite 350San Francisco, CA 94111United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Association services, namely, promoting the interests of gene therapy developers, manufacturers, and research organizations in the fields of genetic medicine, gene therapy, gene delivery, viral capsid technology, and biomanufacturing for gene therapy and gene delivery applications; business networking services in the fields of genetic medicine, gene therapy, gene delivery, viral capsid technology, and biomanufacturing for gene therapy and gene delivery applications; facilitating business connections and collaboration among organizations engaged in gene therapy development, gene delivery, viral capsid technology, and biomanufacturing for gene therapy and gene delivery applications; administration of a business network in the fields of genetic medicine, gene therapy, gene delivery, and viral capsid technology | ACTIVE | May 14, 2025 |
| 042 | Consulting services in the fields of biotechnology, pharmaceutical research and development, genetic science, gene therapy, gene delivery, and viral capsid technology; scientific research and development in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, viral capsid technology, genetic engineering, gene therapeutics, and research tools; biotechnology research services; research and development of new products in the field of gene therapeutics and research tools; providing a collaborative technology network for researchers and organizations in the fields of gene therapy, gene delivery, and viral capsid technology; facilitating scientific collaboration among gene therapy developers, manufacturers, and research organizations in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; providing access to proprietary capsid technologies for use in gene therapy and gene delivery research and development; data sharing services in the fields of biotechnology, gene therapy, and viral capsid technology, namely, coordinating the exchange of scientific and technical data among network participants | ACTIVE | May 14, 2025 |
| 045 | Licensing of intellectual property, namely, licensing of gene therapy capsid technology to network participants; licensing of protein and nucleic acid sequences and methods of use in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; intellectual property licensing services in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; technology transfer services, namely, licensing and transfer of intellectual property in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; administration of licensing programs in the fields of gene therapy and viral capsid technologies | ACTIVE | May 14, 2025 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 16, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 16, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 16, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 8, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 10, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 10, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 10, 2026 | NWAP | NEW APPLICATION ENTERED | — |